Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 6
2014 7
2015 7
2016 3
2017 4
2018 2
2019 3
2020 3
2021 3
2022 4
2023 8
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Druggable genomic landscapes of high-grade gliomas.
Ghanem P, Fatteh M, Kamson DO, Balan A, Chang M, Tao J, Blakeley J; Johns Hopkins Molecular Tumor Board Investigators; Canzoniero J, Grossman SA, Marrone K, Schreck KC, Anagnostou V. Ghanem P, et al. Among authors: kamson do. Front Med (Lausanne). 2023 Dec 8;10:1254955. doi: 10.3389/fmed.2023.1254955. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38143440 Free PMC article.
Disease Assessments in Patients with Glioblastoma.
Phillips KA, Kamson DO, Schiff D. Phillips KA, et al. Among authors: kamson do. Curr Oncol Rep. 2023 Sep;25(9):1057-1069. doi: 10.1007/s11912-023-01440-2. Epub 2023 Jul 20. Curr Oncol Rep. 2023. PMID: 37470973 Review.
Diagnostic Evaluation in Primary CNS Lymphoma.
Lukas RV, Riedell P, Horowitz PM, Pytel P, Kamson DO. Lukas RV, et al. Among authors: kamson do. Neurologist. 2018 Mar;23(2):53-54. doi: 10.1097/NRL.0000000000000169. Neurologist. 2018. PMID: 29494436
Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
Dagher R, Gad M, da Silva de Santana P, Sadeghi MA, Yewedalsew SF, Gujar SK, Yedavalli V, Köhler CA, Khan M, Tavora DGF, Kamson DO, Sair HI, Luna LP. Dagher R, et al. Among authors: kamson do. J Neurooncol. 2024 Jan;166(1):1-15. doi: 10.1007/s11060-023-04528-8. Epub 2024 Jan 11. J Neurooncol. 2024. PMID: 38212574
ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.
Zhang KY, Parker M, Weber-Levine C, Kalluri A, Gonzalez-Gomez I, Raabe E, Dudley JC, Gocke C, Lin MT, Zou Y, Sherief M, Kamson DO, Holdhoff M, Mukherjee D, Croog V, Schreck KC, Rincon-Torroella J, Bettegowda C, Eberhart CG, Bale T, Lucas CG. Zhang KY, et al. Among authors: kamson do. Acta Neuropathol. 2024 Aug 14;148(1):19. doi: 10.1007/s00401-024-02785-z. Acta Neuropathol. 2024. PMID: 39141113 Free PMC article. No abstract available.
Radiation immunodynamics in patients with glioblastoma receiving chemoradiation.
Sloan L, Sen R, Liu C, Doucet M, Blosser L, Katulis L, Kamson DO, Grossman S, Holdhoff M, Redmond KJ, Quon H, Lim M, Eberhart C, Pardoll DM, Hu C, Ganguly S, Kleinberg LR. Sloan L, et al. Among authors: kamson do. Front Immunol. 2024 Sep 13;15:1438044. doi: 10.3389/fimmu.2024.1438044. eCollection 2024. Front Immunol. 2024. PMID: 39346903 Free PMC article.
Dynamic contrast-enhanced CEST MRI using a low molecular weight dextran.
Han Z, Chen C, Xu X, Bai R, Staedtke V, Huang J, Chan KWY, Xu J, Kamson DO, Wen Z, Knutsson L, van Zijl PCM, Liu G. Han Z, et al. Among authors: kamson do. NMR Biomed. 2022 Mar;35(3):e4649. doi: 10.1002/nbm.4649. Epub 2021 Nov 15. NMR Biomed. 2022. PMID: 34779550 Free PMC article.
57 results